RFK Jr. promotes peptides. Now the FDA weighs easing limits on the unproven chemicals In a major policy shift, the U.S. Food and Drug Administration is reconsidering restrictions on several controversial peptides, including trending compounds like BPC 157 and Melanotan II. The move comes as demand for The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York A closer look at the unapproved peptide injections promoted by influencers and celebrities king5.com